Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis

BACKGROUND: The purpose of this study was to stratify patients with rheumatoid arthritis (RA) according to the trend of disease activity by trajectory-based clustering and to identify contributing factors for treatment response to biologic and targeted synthetic disease-modifying anti-rheumatic drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Bon San, Eun, Seongho, Shin, Kichul, Hong, Seokchan, Kim, Yong-Gil, Lee, Chang-Keun, Yoo, Bin, Oh, Ji Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563490/
https://www.ncbi.nlm.nih.gov/pubmed/36242075
http://dx.doi.org/10.1186/s13075-022-02918-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563490/
https://www.ncbi.nlm.nih.gov/pubmed/36242075
http://dx.doi.org/10.1186/s13075-022-02918-3

Ejemplares similares